News
Marketing is designed to stop you in your tracks, and a Cape Town property developer has tested the fine line between cheeky ...
A post-hoc analysis of the DUPLEX trial shows significantly greater improvements in proteinuria-related outcomes vs irbesartan for tough-to-treat FSGS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results